Search research articles
Contact Us
Filters
Showing results (71-80 of 137) with videos related to
Page
of 14
Sort By:
Leukemia & Lymphoma
|
July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response
Caner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.
Blood Advances
|
September 19, 2019
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
Betty K Hamilton, Lisa A Rybicki, David Grove, et al.
Bone Marrow Transplantation
|
February 11, 2023
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel
Agrima Mian, Wei Wei, Betty K Hamilton, et al.
Bone Marrow Transplantation
|
October 10, 2021
Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation
Pranay Hegde, Lisa Rybicki, Sheila Serafino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Remco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 15, 2019
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Brian T Hill, Lisa A Rybicki, Theresa A Urban, et al.
Blood Advances
|
November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase
Vikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 8, 2022
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, et al.
Leukemia
|
October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 7, 2020
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera
Alexander Coltoff, Ruben Mesa, Jason Gotlib, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 137) with videos related to
Sort By:
Page
of 14
Leukemia & Lymphoma
|
July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response
Caner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.
Blood Advances
|
September 19, 2019
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
Betty K Hamilton, Lisa A Rybicki, David Grove, et al.
Bone Marrow Transplantation
|
February 11, 2023
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel
Agrima Mian, Wei Wei, Betty K Hamilton, et al.
Bone Marrow Transplantation
|
October 10, 2021
Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation
Pranay Hegde, Lisa Rybicki, Sheila Serafino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Remco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 15, 2019
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Brian T Hill, Lisa A Rybicki, Theresa A Urban, et al.
Blood Advances
|
November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase
Vikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 8, 2022
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, et al.
Leukemia
|
October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 7, 2020
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera
Alexander Coltoff, Ruben Mesa, Jason Gotlib, et al.
Page
of 14